Transcranial magnetic stimulation
Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It is primarily used to treat depression and other neurological and psychiatric disorders.
History
The concept of using magnetic fields to influence brain activity dates back to the 19th century. However, it was not until 1985 that the first TMS device was developed by Anthony Barker and his colleagues in Sheffield, England. Since then, TMS has evolved significantly and is now widely used in both research and clinical settings.
Mechanism of Action
TMS works by generating a magnetic field that induces an electric current in the brain. This current can modulate neuronal activity, either enhancing or inhibiting it, depending on the frequency and pattern of stimulation. The most common form of TMS is repetitive TMS (rTMS), which involves repeated pulses of magnetic energy.

Clinical Applications
Depression
TMS is most commonly used to treat major depressive disorder (MDD), especially in patients who have not responded to traditional treatments such as medication and psychotherapy. The U.S. Food and Drug Administration (FDA) approved TMS for the treatment of depression in 2008.
Other Disorders
Research is ongoing into the use of TMS for other conditions, including anxiety disorders, schizophrenia, post-traumatic stress disorder (PTSD), and chronic pain.
Procedure
During a TMS session, a coil is placed against the patient's scalp. The coil generates a magnetic field that passes through the skull and into the brain. The procedure is typically performed in an outpatient setting and does not require anesthesia. A typical session lasts about 30 to 60 minutes, and patients usually undergo a series of sessions over several weeks.

Safety and Side Effects
TMS is generally considered safe, with few side effects. The most common side effects include headache, scalp discomfort, and tingling sensations. Rarely, TMS can cause seizures, particularly in individuals with a history of epilepsy.
Research and Future Directions
Ongoing research is exploring the potential of TMS to treat a variety of neurological and psychiatric conditions. Studies are also investigating the use of TMS in combination with other therapies, such as cognitive behavioral therapy (CBT) and pharmacotherapy.

Related Pages
References
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian